141 related articles for article (PubMed ID: 31352073)
1. Dynamic Changes of Health Utility in Lung Cancer Patients Receiving Different Treatments: A 7-Year Follow-up.
Yang SC; Kuo CW; Lai WW; Lin CC; Su WC; Chang SM; Wang JD
J Thorac Oncol; 2019 Nov; 14(11):1892-1900. PubMed ID: 31352073
[TBL] [Abstract][Full Text] [Related]
2. Quality of Life Achieved by Carboplatin Plus Etoposide as Third-Line Chemotherapy Compared with Best Supportive Care in Non-Small Cell Lung Cancer Stage IIIB/IV.
Maneechawakajorn J; Hathaisanguan S
J Med Assoc Thai; 2016 Feb; 99 Suppl 2():S175-81. PubMed ID: 27266233
[TBL] [Abstract][Full Text] [Related]
3. Comparative effectiveness and cost-effectiveness of three first-line EGFR-tyrosine kinase inhibitors: Analysis of real-world data in a tertiary hospital in Taiwan.
Yang SC; Lai WW; Hsu JC; Su WC; Wang JD
PLoS One; 2020; 15(4):e0231413. PubMed ID: 32267879
[TBL] [Abstract][Full Text] [Related]
4. Psychometric properties of the updated EORTC module for assessing quality of life in patients with lung cancer (QLQ-LC29): an international, observational field study.
Koller M; Shamieh O; Hjermstad MJ; Hornslien K; Young T; Chalk T; Ioannidis G; Harle A; Johnson CD; Tomaszewski KA; Serpentini S; Pinto M; van der Weijst L; Janssens A; Morag O; Chie WC; Arraras JI; Pompili C; Jungraithmayr W; Hechtner M; Katsochi D; Müller K; Gräfenstein L; Schulz C; Bottomley A; ; ;
Lancet Oncol; 2020 May; 21(5):723-732. PubMed ID: 32213338
[TBL] [Abstract][Full Text] [Related]
5. Clinical decision-making and health-related quality of life during first-line and maintenance therapy in patients with advanced non-small cell lung cancer (NSCLC): findings from a real-world setting.
Sztankay M; Giesinger JM; Zabernigg A; Krempler E; Pall G; Hilbe W; Burghuber O; Hochmair M; Rumpold G; Doering S; Holzner B
BMC Cancer; 2017 Aug; 17(1):565. PubMed ID: 28835219
[TBL] [Abstract][Full Text] [Related]
6. Estimation of loss of quality-adjusted life expectancy (QALE) for patients with operable versus inoperable lung cancer: adjusting quality-of-life and lead-time bias for utility of surgery.
Yang SC; Lai WW; Chang HY; Su WC; Chen HH; Wang JD
Lung Cancer; 2014 Oct; 86(1):96-101. PubMed ID: 25178685
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of the simplified comorbidity score in the treatment of small cell lung carcinoma.
Kuo YW; Jerng JS; Shih JY; Chen KY; Yu CJ; Yang PC
J Thorac Oncol; 2011 Feb; 6(2):378-83. PubMed ID: 21173715
[TBL] [Abstract][Full Text] [Related]
8. Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
Garassino MC; Gadgeel S; Esteban E; Felip E; Speranza G; Domine M; Hochmair MJ; Powell S; Cheng SY; Bischoff HG; Peled N; Reck M; Hui R; Garon EB; Boyer M; Wei Z; Burke T; Pietanza MC; Rodríguez-Abreu D
Lancet Oncol; 2020 Mar; 21(3):387-397. PubMed ID: 32035514
[TBL] [Abstract][Full Text] [Related]
9. Effect of change in symptoms, respiratory status, nutritional profile and quality of life on response to treatment for advanced non-small cell lung cancer.
Mohan A; Singh P; Kumar S; Mohan C; Pathak AK; Pandey RM; Guleria R
Asian Pac J Cancer Prev; 2008; 9(4):557-62. PubMed ID: 19256738
[TBL] [Abstract][Full Text] [Related]
10. Changes in and Determinants of Quality of Life in Patients With Advanced Non-Small-Cell Lung Cancer Undergoing Initial Chemotherapy.
Dai YL; Yang CT; Chen KH; Tang ST
J Nurs Res; 2017 Jun; 25(3):203-215. PubMed ID: 28481816
[TBL] [Abstract][Full Text] [Related]
11. Quality of life and related factors in patients with newly diagnosed advanced lung cancer: a longitudinal study.
Liao YC; Shun SC; Liao WY; Yu CJ; Yang PC; Lai YH
Oncol Nurs Forum; 2014 Mar; 41(2):E44-55. PubMed ID: 24578085
[TBL] [Abstract][Full Text] [Related]
12. Outcomes in lung cancer: An experience from routine tertiary care setting.
Thippeswamy R; Patil S; Prashanth P; Sateesh CT; Vittal T; Shashidhara HP; Haridas KM
Indian J Cancer; 2017; 54(1):276-279. PubMed ID: 29199705
[TBL] [Abstract][Full Text] [Related]
13. Toxicity and quality of life in published clinical trials for advanced lung cancer.
Zwitter M
Support Care Cancer; 2018 Oct; 26(10):3453-3459. PubMed ID: 29681014
[TBL] [Abstract][Full Text] [Related]
14. The Impact of a Multidimensional Exercise Intervention on Physical and Functional Capacity, Anxiety, and Depression in Patients With Advanced-Stage Lung Cancer Undergoing Chemotherapy.
Quist M; Adamsen L; Rørth M; Laursen JH; Christensen KB; Langer SW
Integr Cancer Ther; 2015 Jul; 14(4):341-9. PubMed ID: 25800229
[TBL] [Abstract][Full Text] [Related]
15. Quality of life and utility in patients with non-small cell lung cancer. Quality-of-life Study Group of the Master 2 Project in Pharmacoeconomics.
Trippoli S; Vaiani M; Lucioni C; Messori A
Pharmacoeconomics; 2001; 19(8):855-63. PubMed ID: 11596837
[TBL] [Abstract][Full Text] [Related]
16. The effects of illness beliefs and chemotherapy impact on quality of life in Japanese and Dutch patients with breast or lung cancer.
van der Kloot WA; Uchida Y; Inoue K; Kobayashi K; Yamaoka K; Nortier HW; Kaptein AA
Chin Clin Oncol; 2016 Feb; 5(1):3. PubMed ID: 26932427
[TBL] [Abstract][Full Text] [Related]
17. Treatment, outcome and quality of life of 1239 patients with advanced non-small cell lung cancer - final results from the prospective German TLK cohort study.
von Verschuer U; Schnell R; Tessen HW; Eggert J; Binninger A; Spring L; Jänicke M; Marschner N;
Lung Cancer; 2017 Oct; 112():216-224. PubMed ID: 28916198
[TBL] [Abstract][Full Text] [Related]
18. Estimating the lifelong health impact and financial burdens of different types of lung cancer.
Yang SC; Lai WW; Su WC; Wu SY; Chen HH; Wu YL; Hung MC; Wang JD
BMC Cancer; 2013 Dec; 13():579. PubMed ID: 24308346
[TBL] [Abstract][Full Text] [Related]
19. Quality of life assessment of second-line docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: results of a prospective, randomized phase III trial.
Dancey J; Shepherd FA; Gralla RJ; Kim YS
Lung Cancer; 2004 Feb; 43(2):183-94. PubMed ID: 14739039
[TBL] [Abstract][Full Text] [Related]
20. Influence of clinical parameters on quality of life during chemotherapy in patients with advanced non-small cell lung cancer: application of a general linear model.
Morita S; Kobayashi K; Eguchi K; Matsumoto T; Shibuya M; Yamaji Y; Sakamoto J; Ohashi Y
Jpn J Clin Oncol; 2003 Sep; 33(9):470-6. PubMed ID: 14594941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
